GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer Invasion

$273,533
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2012 · CA

Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer Invasion

$273,533
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2011 · CA

The Macropinosome: Uncovering the Molecular Anatomy of an Oncogene-driven Organelle

$273,488
Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2020 · CA

Pharmacodiagnotics through Molecular Clues

$273,477
Scott E Kern · Johns Hopkins University · P50 · FY2008 · CA

Structural Biology Shared Facility

$273,330
Lawrence J Delucas · University Of Alabama At Birmingham · P30 · FY2018 · CA

Computational Analysis Core

$273,171
Douglas A Lauffenburger · Massachusetts Institute Of Technology · U54 · FY2018 · CA

NOVEL KINASE SIGNALING CASCADES IN PANCREATIC ACINI

$273,099
University Of Michigan At Ann Arbor · R01 · FY2001 · DK

High throughput screens for fatty acid uptake inhibitors

$273,061
Concetta C. Dirusso · University Of Nebraska Lincoln · R01 · FY2008 · DK

Embryonic Signaling Pathways in Pancreatic Cancer

$272,949
Matthias Hebrok · University Of California, San Francisco · R01 · FY2006 · CA

Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer

$272,944
Conan Kinsey · University Of Utah · K08 · FY2022 · CA

Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer

$272,944
Conan Kinsey · University Of Utah · K08 · FY2021 · CA

Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer

$272,944
Conan Kinsey · University Of Utah · K08 · FY2020 · CA

Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer

$272,944
Conan Kinsey · University Of Utah · K08 · FY2024 · CA

Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer

$272,944
Conan Kinsey · University Of Utah · K08 · FY2023 · CA

Embryonic signaling pathways in pancreatic cancer

$272,869
Matthias Hebrok · University Of California, San Francisco · R01 · FY2010 · CA

The Role of p16INK4a in Mammalian Aging

$272,833
Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2013 · AG

Great Lakes New England Clinical Validation Center

$272,820
Dean E. Brenner · University Of Michigan At Ann Arbor · U01 · FY2019 · CA

Cytosolic Phospholipase in Transformed Cells

$272,694
University Of Colorado Denver · R01 · FY2003 · CA

The GABA-B receptor is a novel drug target for pancreatic cancer

$272,655
Hildegard Schuller · University Of Tennessee Knoxville · R01 · FY2010 · CA

The GABA-B receptor is a novel drug target for pancreatic cancer

$272,655
Hildegard Schuller · University Of Tennessee Knoxville · R01 · FY2009 · CA

Administrative Supplement for Stanford Unit: CPDPC

$272,546
Walter Gwang-Up Park · Stanford University · U01 · FY2018 · DK

Clinical Managment and Trials Core and Advocacy Sub-Core

$272,534
Selwyn M Vickers · University Of Alabama At Birmingham · P50 · FY2012 · CA

Developing novel CAR T cell designs using combinatorial antigen detection

$272,518
Greg Maness Allen · University Of California, San Francisco · K08 · FY2025 · CA

Early Detection of Human Colorectal and Pancreatic Cancer

$272,424
Kenneth W. Kinzler · Johns Hopkins University · P50 · FY2007 · CA

Applications of "Recombomice" for Cancer Research

$272,319
Bevin P. Engelward · Massachusetts Institute Of Technology · R33 · FY2007 · CA